Intracoronary administration of allogeneic adipose tissue-derived mesenchymal stem cells improves myocardial perfusion but not left ventricle function, in a translational model of acute myocardial infarction

Journal of the American Heart Association

Volumn 6, Issue 5, 2017, Pages

  Bobi, Joaquim ^a   Solanes, Núria ^a   Fernández Jiménez, Rodrigo ^b,c,n   Galán Arriola, Carlos ^b,n   Dantas, Ana Paula ^a   Fernández Friera, Leticia ^b,d,n   Gálvez Montón, Carolina ^e,n   Rigol Monzó, Elisabet ^f   Agüero, Jaume ^b,n,o   Ramírez, José ^g   Roqué, Mercè ^a   Bayés Genís, Antoni ^e,h,i,j,n   Sánchez González, Javier ^k   García Álvarez, Ana ^a,b   Sabaté, Manel ^a   Roura, Santiago ^e,l,n   Ibáñez, Borja ^b,m,n   Rigol, Montserrat ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Hospital Universitario HM Monteprincipe   (Spain)

^e Germans Trias i Pujol Research Institute in Health Sciences   (Spain)

^f Inst Clin d'Infec Immunol (ICII)   (Spain)

^g Servei d'Anatomia Patològica   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^j UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^k PHILIPS HEALTHCARE   (United States)

^l CENTER OF REGENERATIVE MEDICINE IN BARCELONA   (Spain)

^m UAM)   (Spain)

ⁿ CIBERCV   (Spain)

^o HOSPITAL UNIVERSITARIO LA FE   (Spain)

more..

Author keywords

Adipose tissue derived mesenchymal stem cells; Allogeneic origin; Myocardial infarction; Myocardial perfusion; Vascular density

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; ANGIOGENIC PROTEIN; CYTOKINE; GREEN FLUORESCENT PROTEIN;

ACUTE HEART INFARCTION; ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HEART PROTECTION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; ALLOTRANSPLANTATION; ANGIOGENESIS; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVALESCENCE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CYTOLOGY; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; HEART INFARCTION; MESENCHYMAL STROMA CELL; METABOLISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PIG; PROCEDURES; REGENERATION; SCINTIGRAPHY; TIME FACTOR;

ADIPOSE TISSUE; ANGIOGENIC PROTEINS; ANIMALS; CELLS, CULTURED; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CYTOKINES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PERFUSION IMAGING; RECOVERY OF FUNCTION; REGENERATION; SUS SCROFA; TIME FACTORS; TRANSFECTION; TRANSPLANTATION, HOMOLOGOUS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 85019349113     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.005771     Document Type: Article

References (49)

1. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair- lessons from clinical trials. Nat Rev Cardiol. 2014;11:232-246.
2. Srijaya TC, Ramasamy TS, Kasim NHA. Advancing stem cell therapy from bench to bedside: lessons from drug therapies. J Transl Med. 2014;12:243.
3. Jimenez-Quevedo P, Gonzalez-Ferrer JJ, Sabate M, Garcia-Moll X, Delgado-Bolton R, Llorente L, Bernardo E, Ortega-Pozzi A, Hernandez-Antolin R, Alfonso F, Gonzalo N, Escaned J, Banuelos C, Regueiro A, Marin P, Fernandez-Ortiz A, Das Neves B, Del Trigo M, Fernandez C, Tejerina T, Redondo S, Garcia E, Macaya C. Selected CD133+ progenitor cells to promote angiogenesis in patients with refractory angina final results of the PROGENITOR randomized trial. Circ Res. 2014;115:950-960.
4. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857.
5. Wang L, Deng J, Tian W, Xiang B, Yang T, Li G, Wang J, Gruwel M, Kashour T, Rendell J, Glogowski M, Tomanek B, Freed D, Deslauriers R, Arora RC, Tian G. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol. 2009;297:H1020-H1031.
6. Yang J, Yang X, Liu Z, Hu S, Du Z, Feng L, Liu J, Chen Y. Transplantation of adipose tissue-derived stem cells overexpressing heme pxygenase-1 improves functions and remodeling of infarcted myocardium in rabbits. Tohoku J Exp Med. 2012;226:231-241.
7. Chen YL, Sun CK, Tsai TH, Chang LT, Leu S, Zhen YY, Sheu JJ, Chua S, Yeh KH, Lu HI, Chang HW, Lee FY, Yip HK. Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction. Am J Transl Res. 2015;7:781-803.
8. Chen L, Qin F, Ge M, Shu Q, Xu J. Application of adipose-derived stem cells in heart disease. J Cardiovasc Transl Res. 2014;7:651-663.
9. Badimon L, Onate B, Vilahur G. Adipose-derived mesenchymal stem cells and their reparative potential in ischemic heart disease. Rev Esp Cardiol (Engl Ed). 2015;68:599-611.
10. Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease. World J Cardiol. 2015;7:454-465.
11. Rigol M, Solanes N, Roura S, Roque M, Novensá L, Dantas AP, Martorell J, Sitges M, Ramirez J, Bayes-Genis A, Heras M. Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest. 2014;44:83-92.
12. Golpanian S, Rico L, Herrera C. Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation? Stem Cells Transl Med. 2012;1:403-408.
13. Jansen Of Lorkeers SJ, Eding JEC, Vesterinen HM, Van Der Spoel TIG, Sena ES, Duckers HJ, Doevendans PA, Macleod MR, Chamuleau SAJ. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circ Res. 2015;116:80-86.
14. Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308:2369-2379.
15. Rigol M, Solanes N, Farre J, Roura S, Roque M, Berruezo A, Bellera N, Novensá L, Tamborero D, Prat-Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramirez J, Dantas AP, Merino A, Sanz G, Brugada J, Bayes-Genis A, Heras M. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J Card Fail. 2010;16:357-366.
16. Perea-Gil I, Prat-Vidal C, Galvez-Monton C, Roura S, Lluciá-Valldeperas A, Soler-Botija C, Iborra-Egea O, Diaz-Güemes I, Crisostomo V, Sanchez-Margallo FM, Bayes-Genis A. A cell-enriched engineered myocardial graft limits infarct size and improves cardiac function. JACC Basic Transl Sci. 2016;1:360-372.
17. Garçia-Prieto J, Garçia-Ruiz JM, Sanz-Rosa D, Pun A, Garçia-Alvarez A, Davidson SM, Fernandez-Friera L, Nuno-Ayala M, Fernandez-Jimenez R, Bernal JA, Izquierdo-Garcia JL, Jimenez-Borreguero J, Pizarro G, Ruiz-Cabello J, Macaya C, Fuster V, Yellon DM, Ibanez B. B3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res Cardiol. 2014;109:422.
18. Fernandez-Jimenez R, Sanchez-Gonzalez J, Agüero J, Garçia-Prieto J, Lopez-Martin GJ, Garçia-Ruiz JM, Molina-Iracheta A, Rossell X, Fernandez-Friera L, Pizarro G, Garçia-Alvarez A, Dall'Armellina E, Macaya C, Choudhury RP, Fuster V, Ibanez B. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol. 2015;65:315-323.
19. Fernandez-Jimenez R, Garçia-Prieto J, Sanchez-Gonzalez J, Agüero J, Lopez-Martin GJ, Galan-Arriola C, Molina-Iracheta A, Doohan R, Fuster V, Ibanez B. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J Am Coll Cardiol. 2015;66:816-828.
20. Ibanez B, Fuster V, Macaya C, Sanchez-Brunete V, Pizarro G, Lopez-Romero P, Mateos A, Jimenez-Borreguero J, Fernandez-Ortiz A, Sanz G, Fernandez-Friera L, Corral E, Barreiro MV, Ruiz-Mateos B, Goicolea J, Hernandez-Antolin R, Acebal C, Garçia-Rubira JC, Albarran A, Zamorano JL, Casado I, Valenciano J, Fernandez-Vazquez F, De La Torre JM, Perez De Prado A, Iglesias-Vazquez JA, Martinez-Tenorio P, Iniguez A. Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment. Am Heart J. 2012;164:473-480.e5.
21. Garçia-Ruiz JM, Fernandez-Jimenez R, Garçia-Alvarez A, Pizarro G, Galan-Arriola C, Fernandez-Friera L, Mateos A, Nuno-Ayala M, Aguero J, Sanchez-Gonzalez J, Garçia-Prieto J, Lopez-Melgar B, Martinez-Tenorio P, Lopez-Martin GJ, Maçias A, Perez-Asenjo B, Cabrera JA, Fernandez-Ortiz A, Fuster V, Ibanez B. Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol. 2016;67:2093-2104.
22. Sanchez-Gonzalez J, Fernandez-Jimenez R, Nothnagel ND, Lopez-Martin G, Fuster V, Ibanez B. Optimization of dual-saturation single bolus acquisition for quantitative cardiac perfusion and myocardial blood flow maps. J Cardiovasc Magn Reson. 2015;17:21.
23. Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP. Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17Bestradiol. Hypertension. 2010;56:405-411.
24. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LEJ, Berman D, Czer LSC, Marban L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379:895-904.
25. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, Lange R, Marban E. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009;120:1075-1083.
26. Gallet R, Tseliou E, Dawkins J, Middleton R, Valle J, Angert D, Reich H, Luthringer D, Kreke M, Smith R, Marban L, Marban E. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ Cardiovasc Interv. 2015;8:e002391.
27. Lee HW, Lee HC, Park JH, Kim BW, Ahn J, Kim JH, Park JS, Oh JH, Choi JH, Cha KS, Hong TJ, Park TS, Kim SP, Song S, Kim JY, Park MH, Jung JS. Effects of intracoronary administration of autologous adipose tissue-derived stem cells on acute myocardial infarction in a porcine model. Yonsei Med J. 2015;56:1522-1529.
28. Mu D, Zhang X, Xie J, Yuan H, Wang K, Huang W. Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin-linked kinase improves cardiac function in porcine myocardial infarction. Sci Rep. 2016;6:19155.
29. Houtgraaf JH, De Jong R, Kazemi K, De Groot D, Van Der Spoel TIG, Arslan F, Hoefer I, Pasterkamp G, Itescu S, Zijlstra F, Geleijnse ML, Serruys PW, Duckers HJ. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Circ Res. 2013;113:153-166.
30. Ibanez B, Heusch G, Ovize M, Van De Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65:1454-1471.
31. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, Le Jemtel TH, Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007;28:2667-2677.
32. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441-1448.
33. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
34. Kitazawa Y, Li XK, Xie L, Zhu P, Kimur H, Takahara S. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats. Cell Transplant. 2012;21:581-590.
35. Kanazawa H, Tseliou E, Dawkins JF, De Couto G, Gallet R, Malliaras K, Yee K, Kreke M, Valle I, Smith RR, Middleton RC, Ho C-S, Dharmakumar R, Li D, Makkar RR, Fukuda K, Marban L, Marban E. Durable benefits of cellular postconditioning: long-term effects of allogeneic cardiosphere-derived cells infused after reperfusion in pigs with acute myocardial infarction. J Am Heart Assoc. 2016;5:e002796. DOI: 10.1161/JAHA.115.002796.
36. Ock SA, Baregundi Subbarao R, Lee YM, Lee JH, Jeon RH, Lee SL, Park JK, Hwang SC, Rho GJ. Comparison of immunomodulation properties of porcine mesenchymal stromal/stem cells derived from the bone marrow, adipose tissue, and dermal skin tissue. Stem Cells Int. 2016;2016:15.
37. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, Mazhari R, Boyle AJ, Zambrano JP, Rodriguez JE, Dulce R, Pattany PM, Valdes D, Revilla C, Heldman AW, McNiece I, Hare JM. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010;107:913-922.
38. Adutler-Lieber S, Ben-Mordechai T, Naftali-Shani N, Asher E, Loberman D, Raanani E, Leor J. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Ther. 2012;18:78-86.
39. Ebrahimi B, Eirin A, Li Z, Zhu X-Y, Zhang X, Lerman A, Textor SC, Lerman LO. Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. PLoS One. 2013;8:e67474.
40. van den Akker F, Deddens JC, Doevendans PA, Sluijter JPG. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. Biochim Biophys Acta. 2013;1830:2449-2458.
41. Mazo M, Hernandez S, Gavira JJ, Abizanda G, Arana M, Lopez-Martinez T, Moreno C, Merino J, Martino-Rodriguez A, Uixeira A, Garçia de Jalon JA, Pastrana J, Martinez-Caro D, Prosper F. Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction. Cell Transplant. 2012;21:2723-2733.
42. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells. 2012;30:1030-1041.
43. Yang D, Wang W, Li L, Peng Y, Chen P, Huang H, Guo Y, Xia X, Wang Y, Wang H, Wang WE, Zeng C. The relative contribution of paracrine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair. PLoS One. 2013;8:1-11.
44. Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J, Gardner TJ, Sweeney HL. Induction of angiogenesis and inhibition of apoptosis by hepatocyte postischemic heart failure. J Card Surg. 2005;20:93-101.
45. Ellison GM, Torella D, Dellegrottaglie S, Perez-Martinez C, Perez De Prado A, Vicinanza C, Purushothaman S, Galuppo V, Iaconetti C, Waring CD, Smith A, Torella M, Cuellas Ramon C, Gonzalo-Orden JM, Agosti V, Indolfi C, Galianes M, Fernandez-Vazquez F, Nadal-Ginard B. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011;58:977-986.
46. Gomez-Mauricio G, Moscoso I, Martin-Cancho M-F, Crisostomo V, Prat-Vidal C, Baez-Diaz C, Sanchez-Margallo FM, Bernad A. Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model. Stem Cell Res Ther. 2016;7:94.
47. Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, Mu H, Pachori A, Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA. 2007;104:1643-1648.
48. Voorhees AP, DeLeon-Pennell KY, Ma Y, Halade GV, Yabluchanskiy A, Iyer RP, Flynn E, Cates CA, Lindsey ML, Han H-C. Building a better infarct: modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction. J Mol Cell Cardiol. 2015;85:229-239.
49. Fernandez-Jimenez R, Fernandez-Friera L, Sanchez-Gonzalez J, Ibanez B. Animal models of tissue characterization of area at risk, edema and fibrosis. Curr Cardiovasc Imaging Rep. 2014;7:1-10.